Centre Hospitalier Departemental Vendee — Clinical Trial Site

206 Registered trials

96 Currently recruiting

Organisation

Centre Hospitalier Departemental Vendee

Location

La Roche Sur Yon Cedex 9, France

Identifier

ORG-100007266

Address

Boulevard Stephane Moreau, 85925, France

Departments

033019: Interne Onco-Hematologie
12-032 Onco-hématologie
1507:Medical Oncology
410: Service Onco-Hematologie
85925
Algology
Anaestesia
Anaesthesiology
Anesthésie
Cardiologie, Chirurgie digestive et Hépato-gastro-entérologie
Cardiology
Centre d’évaluation et de traitement de la douleur
Centre Hospitalier Départemental Vendée
Centre Hospitalier Départemental Vendée - Service de Rhumatologie
Département d'Hépato-Gastro-Entérologie
Departement de Cardiologie
Département de Médecine ORL et Chirurgie Cervico Faciale
Département Onco-Hématologie
Département Oncologie-Hématologie
Department of Onco-Hematology
Department of Rheumatology
Dermatology
Digestive surgery
ENT Department
FR10013: Département d’Hépato-Gastro-Entérologie
GASTRO ENTEROLOGY
GASTRO-ENTEROLOGIE ET HEPATOLOGIE
Gastroenterolgy
Gastroentérologie
Gastroenterology
Gastroenterology and Hepatology
geriatric medicine
Haematology
Heamato-oncology
Hemato-Oncologie
Hemato-oncology
Hématologie
Hématologie - Oncologie
Hematology
Hépato-gastro-entérologie
Hepato-gastro-enterology
Hepato-gastroenterology
Hepato-Gastroenterology Department
Hepatogastroenterology
ICU
Imagerie Médicale
INFECTIOLOGY
Infectious diseas
Infectious disease
Infectious diseases
Intensive care
Intensive Care Department
Intensive Care Unit
Maladies Infectieuses et Tropicales
Médecine Générale
Médecine intensive – réanimation
Médecine post-urgence – maladies infectieuses
Medical Oncology
Multipurpose intensive care
N/A
NA
Néphrologie
Nephrology
Neurology
Onco hematology
Onco-Haematology
onco-hematologie
Onco-Hematology
Oncologie
Oncologie Hématologie
Oncologie Médicale
Oncology
oncology department
Oncology-Hematology
Pneumologie
Pneumology
Pneumonology Department
Pôle Médecine Onco-Hématologie
Post Emergencies Medecine and Infectious Diseases
Post Emergencies Medicine and infectious diseases
Radiothérapie
Radiotherapy Oncology
Réanimation
Réanimation polyvalente
Recherche Clinique
Rheumatology
Rhumatologie
Service d'Hepato-gastro-enterologie
Service d'hépato-gastroentérologie
Service d'Onco-hématologie
service d'oncologie
Service d’Hémato-Oncologie
Service d’Onco-Hématologie
Service de Cardiologie
Service de Hépato-Gastro-Enterologie
Service de Médecine Intensive Réanimation
service de médecine post-urgence – maladies infectieuses
Service de Néphrologie
Service de pneumologie
Service de Réanimation polyvalente
Service de soins intensifs
Service onco hématologie
Service Oncologie
Service Pneumologie
SMIT
Unité de Recherche Clinique
Unité de Recherche Clinique Onco-Hematologie
Unité de Soins intensifs
Vendee

Clinical trials at this site (206)

Search interface

Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 10 2025-11-28
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obe… Recruiting

2024-520209-38-00 Obesity or Overweight 5 2025-09-19
A Study to Assess the Effectiveness and Safety of Induction Therapy with RO7790121 in Participants with Moderately to Severely Active Crohn'… Recruiting

2024-513054-30-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting

2023-507853-13-00 Ulcerative Colitis 4 2025-02-25
ISASOCUT-IFM2022-05-Multicenter phase 2 study of subcutaneous isatuximab plus bortezomib, lenalidomide and dexamethasone in the treatment of… Recruiting

2024-517099-39-00 Newly diagnosed transplant ineligible multiple myeloma 4 2024-11-18
Lessening Organ Dysfunction with VITamin C in septic ARDS Recruiting

2024-516394-78-00 Patient with sepsis complicated by ARDS 5 2024-11-05
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting

2024-517004-11-00 Chronic pulmonary aspergillosis 5 2024-10-22
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with a… Recruiting

2023-509606-30-00 Ulcerative colitis 5 2024-07-24
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma Recruiting

2023-505775-70-00 High risk smoldering multiple myeloma 4 2024-04-08
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Small bowel adenocarcinoma 4 2024-02-09
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
AMUNDSEN - Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI)… Recruiting

2024-518195-31-00 acute myocardial infarction 6 2021-09-29
An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the l… Recruiting

2024-511267-28-00 B-cell malignancies 5 2021-02-17
A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethaso… Recruiting

2024-511855-16-00 Onco-hematology 5 2019-07-25
Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement Recruiting

2024-519620-24-01 ANCA-associated vasculitis 5 2026-06-01
PIPELINE-RSV-France Recruiting

2025-521755-23-00 Respiratory syncytial virus infection 5 2026-04-28
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma Recruiting

2024-519208-29-00 Pleural mesothelioma 4 2026-04-02
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
BEvacizumab plus Trifluridine/tipiracil in a bi-WEEkly administration to reduce grade 3-4 Neutropenia in patients with mCRC: A prospective, … Recruiting

2024-520128-27-00 colorectal adenocarcinoma 4 2026-03-04
PRODIGE 115 (FFCD 2406) ULYSSE : FOLFOX/FOLFIRI + Bévacizumab ou Fruquintinib en 2ème ligne du Cancer Colorectal métastatique (CCRm) : essai… Recruiting

2025-522108-26-00 métastatique colorectal cancer 4 2026-02-19
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer Recruiting

2025-521904-23-00 Locally Advanced Inoperable or Metastatic Breast Cancer 4 2026-02-17
A Study to Learn About the Investigational Medicine Called Mevrometostat (PF-06821497) in Men With Metastatic Castration-Sensitive Prostate … Recruiting

2024-519369-24-00 METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER 5 2026-01-29
FILOWM4-WaZaBi: "Open label phase 2 study evaluating the efficacy and tolerance of a zanubrutinib and BGB-11417 combination in patients prev… Recruiting

2023-505781-28-00 Patients with Waldenstrom macroglobulinemia and have re 4 2026-01-20